Hypertensive patients with Raynaud's phenomenon or intermittent claudication and their treatment with ketanserin.
van Oene
J C
JC
Department of Clinical Research, Janssen Pharmaceutica B.V., Tilburg, The Netherlands.
D006801:Humans; D006973:Hypertension / Q000150:complications / Q000188:drug therapy*; D007383:Intermittent Claudication / Q000150:complications / Q000188:drug therapy*; D007650:Ketanserin / Q000009:adverse effects / Q000627:therapeutic use*; D011928:Raynaud Disease / Q000150:complications / Q000188:drug therapy*
D007650:Ketanserin